FLASHDOSE - Trademark Details
Status: 606 - Abandoned - No Statement Of Use Filed
Serial Number
78543928
Word Mark
FLASHDOSE
Status
606 - Abandoned - No Statement Of Use Filed
Status Date
2009-08-24
Filing Date
2005-01-07
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2006-05-02
Attorney Name
Law Office Assigned Location Code
M20
Employee Name
REIHNER, DAVID C
Statements
Goods and Services
Pharmaceutical preparations and substances for the prevention, treatment and alleviation of stress; pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; pharmaceutical preparations and substances for controlling insulin levels; pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension; pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; pharmaceutical preparations and substances for the cessation of smoking; pharmaceutical preparations and substances for the prevention and treatment of sexually transmitted diseases; pharmaceutical preparations and substances for the prevention and treatment of herpes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of depression; anti-depressants; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sleep disorders; pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardio-vascular system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; pharmaceutical preparations and substances for the prevention, treatment and alleviation of asymptomatic left ventricular dysfunction; pharmaceutical preparations and substances, namely, fibrinolytic or thrombolytic agents; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the respiratory system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the endocrine system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the immune system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the musculo-skeletal system, namely, bone diseases and bone degenerative conditions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain and inflammation, namely, pain relief medication and anti-inflammatories; pharmaceutical preparations and substances for the prevention, treatment and alleviation of migraines; pharmaceutical preparations and substances, namely, medicated skin care preparations for use in dermatology, namely, dermatitis and skin pigmentation diseases; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for use in ophthalmology; pharmaceutical preparations and substances for the treatment of polycystic ovary syndrome; pharmaceutical preparations and substances for the treatment of infertility; pharmaceutical preparations and substances for the prevention, treatment and alleviation circulatory, neurologic, alimentary, auto-immune, pulmonary, musculoskeletal, lymphatic, gastrointestinal, bone sensory, viral, urinary, renal, infectious or metabolic diseases, illnesses, disorders or conditions; metformin; diltiazem; tramadol; carvedilol; bupropion; metoprolol; citalopram; zolpidem; fluoxetine; venlafaxine; lorazepam; and sumatriptan
Pseudo Mark
FLASH DOSE
Classification Information
International Class
5 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2005-01-19
Primary Code
005
Correspondences
Name
James R. Menker
Address
Please log in with your Justia account to see this address.
Prior Registrations
Relationship Type | Reel Number |
Prior Registration | 2048066 |
Trademark Events
Event Date | Event Description |
2005-01-19 | NEW APPLICATION ENTERED IN TRAM |
2005-04-13 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2005-08-09 | ASSIGNED TO EXAMINER |
2005-08-09 | NON-FINAL ACTION WRITTEN |
2005-08-09 | NON-FINAL ACTION E-MAILED |
2006-02-09 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2006-02-09 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2006-03-03 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2006-03-08 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2006-03-10 | ASSIGNED TO LIE |
2006-03-14 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
2006-04-12 | NOTICE OF PUBLICATION |
2006-05-02 | PUBLISHED FOR OPPOSITION |
2006-07-25 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
2006-11-09 | TEAS EXTENSION RECEIVED |
2006-11-09 | EXTENSION 1 FILED |
2006-12-27 | EXTENSION 1 GRANTED |
2007-07-12 | TEAS EXTENSION RECEIVED |
2007-07-12 | EXTENSION 2 FILED |
2007-09-14 | EXTENSION 2 GRANTED |
2007-09-29 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2008-01-18 | TEAS EXTENSION RECEIVED |
2008-01-18 | EXTENSION 3 FILED |
2008-02-07 | EXTENSION 3 GRANTED |
2008-07-17 | TEAS EXTENSION RECEIVED |
2008-07-17 | EXTENSION 4 FILED |
2008-07-17 | EXTENSION 4 GRANTED |
2009-01-22 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
2009-01-22 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
2009-01-22 | TEAS EXTENSION RECEIVED |
2009-02-05 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
2009-01-22 | EXTENSION 5 FILED |
2009-02-05 | EXTENSION 5 GRANTED |
2009-06-17 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
2009-08-24 | ABANDONMENT - NO USE STATEMENT FILED |
2009-08-24 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
2010-10-13 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |